To view Track names, descriptions, objectives and target audience, click here.

Sessions scheduled on Wednesday, April 27 at 1:15, 2:30 and 3:45 are for RCM CLIENTS ONLY

SCM and other clients are not eligible to attend these sessions and will be participating in the Vendor Fair at this time.

*Accreditations appearing on this website are pending approval by the appropriate crediting agencies. Although MedAssets does not anticipate any denials, pleae check the signage outside the session room for final approvals.

QuVa Pharma, Inc.


United States
  • Booth: 743

QuVa Pharma, Inc., a newly formed national platform for compounded sterile and non-sterile preparations, is an emerging leader in 503B outsourcing services. Founded by a team of industry executives with deep cGMP and FDA experience, QuVa is committed to exceeding safety standards and providing partnership-oriented customer service. QuVa’s patient-centric approach involves the highest industry standards where every batch undergoes USP 71 sterility, USP 85 endotoxin, and HPLC potency testing before being released.